undamentalytics Newsletter
Sign in

Cerenome, Inc. balance sheet

At the end of fiscal 2025, Cerenome, Inc. had total assets of $16.3m, total liabilities of $12.3m and shareholders' equity of $4.0m. It held $4.3m in cash against $750,000 of debt: net cash of $3.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents13533726161514131059042
Receivables—224411100————
Inventory—333454430————
Total current assets—5943342522211915101051512
Goodwill—4444444400000
Total assets—6652434239383532241171614
Accounts payable——02111111593—
Total current liabilities—13818151681318181116129
Short-term debt—6210370714144———
Long-term debt—132213231817110—————
Total debt02024232625171814144310
Total liabilities—4342373944252419191316129
Shareholders' equity−4231063−61211135−1−945
Net debt (negative = net cash)−13−33−12−311112549−53−4−2
Shares outstanding——————————31m—83m7m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CNSY vs INBSBMRA vs CNSYCNSY vs MCTACNSY vs ICCM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cerenome, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cerenome, Inc.